Pharma Focus Asia

Lupin Digital Health Launches LYFE, Digital Therapeutic Solution

Wednesday, January 25, 2023

Lupin Digital Health, a wholly-owned subsidiary of global pharma major Lupin, announced the launch of its digital therapeutics solution, LYFE.

LYFE helps patients in improving their heart health through doctor-connected online and offline modules. LYFE’s simple and intuitive interface offers medication reminders, 24X7 emergency and ambulance assistance. Moreover, LYFE offers expert intervention in the form of dedicated care managers, health coaches and nutritionists. LYFE is an end-to-end solution for cardiac patients, in accordance with protocols designed by their treating cardiologists.

Designed with leading cardiologist’s inputs, LYFE improves the quality of life of patients and reduces the stress and anxiety of their caregiver.

Patients with chronic cardiovascular diseases experience higher uncertainty and require significant care and monitoring. With LYFE, a digital therapy platform, enables the power of human intelligence and AI/ML to improve patient outcomes by enhancing physician-patient collaboration, continuously monitoring health factors, increasing patient awareness and improving adherence.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024